아스트라제네카도 좋은 백신입니다.

이 기사가 말하는 텔레그래프의 24일 기사는 'https://www.telegraph.co.uk/business/2021/08/24/doubts-grow-future-astrazenecas-covid-vaccine/' 이걸로 보이는데, 번역해 소개할꺼면 주요 논지와 근거는 다 소개해야하지 않을까요. 정치적인 의도로 원 기사를 부적절하게 인용해 쓴걸로 보여요. 혈전문제로 아스트라제네카 평판문제가 있음을 무시할 수는 없지만 여전히 아스트라제네카가 최고의 백신이라 생각하며, 아스트라제네카로 부스터샷 맞자고 의견낼꺼라는 전 백신TF장의 인터뷰는 절반이상 잘린채로 인용되었고. 지난달 아스트라제네카가 화이자에 비해 적게 사용된 것은 아스트라제네카 접종연령(40세 이상)은 이미 대부분 백신접종이 완료되어서라고 바로 설명해놨는데 그냥 빼놨네요.


"I find it all a little bit disturbing," said Clive Dix, the former interim chair of the vaccine taskforce. "I think it's crazy we're going down that route [to buy doses for 2022] already." In his view, decisions over boosting seem to be rushed.

"I would personally just say let's boost with the AstraZeneca vaccine this year, which we have available and which is a very good vaccine - and only then should we start thinking about next year."

Still, while he sees AstraZeneca's vaccine as among the best, he says it is hard to ignore its "tarnished reputation" - centred around concerns over the few cases of blood clots associated with the jab. A study recently suggested rates of clots were "similar" with Pfizer's vaccine.

"It's so sad that both as a British company and one of the front-running companies with vaccines, it seems to have this reputation," Dix shrugs. "It rolled up its sleeves and did something really important."


---

Between July 21 and August 11, only 700,000 AstraZeneca vaccines were administered across the UK - driven by the fact it is only advised for those over 40, many of whom had already been vaccinated. During that same period, 3.2m Pfizer doses were given.